PRPH: ProPhase Labs, Inc. Stock

by  •  • Comments Off on PRPH: ProPhase Labs, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.74
Enterprise Value ($M) 25.92
Book Value ($M) 7.35
Book Value / Share 0.18
Price / Book 1.60
NCAV ($M) -25.21
NCAV / Share -0.60
Price / NCAV -0.47

Profitability (mra)
Return on Invested Capital (ROIC) -1.67
Return on Assets (ROA) -0.59
Return on Equity (ROE) -1.19

Liquidity (mrq)
Quick Ratio 0.92
Current Ratio 0.95

Balance Sheet (mrq) ($M)
Current Assets 30.64
Assets 63.20
Liabilities 55.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.77
Operating Income -38.63
Net Income -53.36
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.54
Cash from Investing 2.42
Cash from Financing 14.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2024-03-19 13D/A Karkus Ted William 20.30 2.79

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 290,660 538,630 53.96
2025-04-16 180,420 470,519 38.34
2025-04-15 78,433 420,955 18.63
2025-04-14 402,325 1,077,931 37.32

(click for more detail)

Similar Companies
PMN – ProMIS Neurosciences, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp. PRQR – ProQR Therapeutics N.V.
PRTG – Portage Biotech Inc.


Financial data and stock pages provided by
Fintel.io